RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Korea Investment & Securities
K

Korea Investment & Securities portfolio

Korea Investment & Securities has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $106.5M.
Latest deal: Vedanta Biosciences · May 2, 2023.
About this page

Its most recent investment on record is Vedanta Biosciences's $106.5M Series B+ round in May 2023, alongside AXA Investment Managers, Peak 6, Skyviews Life Science and 8 others. That company is in Health and bio.

What Korea Investment & Securities invests in

How Korea Investment & Securities invests

StageDealsCapital in rounds
Series B+ 1 100%$106.5M

Korea Investment & Securities portfolio companies

CompanyRound with Korea Investment & SecuritiesTotal raisedLatest raise
VVedanta Biosciences
Health and bio
Series B+ · $106.5M$166.5MAug 6, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Korea Investment & Securities. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Korea Investment & Securities, which is a subset of its real portfolio. API: /api/v1/investors/korea-investment-securities (get a free API key). More: the most active VC firms and new venture capital funds.